October 11, 2019
We recently identified the ten most difficult examiners currently reviewing applications at the USPTO. Our research prompted the question: “Which firms and companies have prosecuted the most applications in front of these difficult examiners?”
October 07, 2019
In an update to our 2016, 2017, and 2018 lists of most difficult examiners at the USPTO, we have identified the 10 patent examiners (excluding SPEs) with the most skeptical eye toward the patent applications that cross their desks.
August 08, 2019
The USPTO recently hosted a webinar about the general approach to interpreting claims and how the specification interacts with and modifies those claims. With the goal of providing answers to common examiner questions, the webinar specifically discussed the importance of the broadest reasonable interpretation (BRI) of each claim, how to handle claim limitations, and the added difficulty of...
United Technologies, an American multinational conglomerate, recently agreed to combine its aerospace business with military contractor Raytheon, creating a new manufacturing giant in the aerospace and defense sectors. Under the new name of Raytheon Technologies, the merged company would have about $74 billion in expected sales for 2019.
May 07, 2019
Sprint and T-Mobile recently announced that they had reached a deal to merge, promising to “be a force for positive change in the U.S. wireless, video, and broadband industries.” Combining the country’s third and fourth largest mobile service providers would be one of the most significant consolidations in the American wireless market in years.
March 25, 2019
Due to inconsistent interpretation, preparing for and responding to Alice rejections has become one of the most stressful aspects of patent prosecution. Rejections citing Alice have multiplied exponentially since the initial decision on June 19, 2014, and they now account for more than 60% of §101 rejections and more than 8% of all rejections, as of our latest analysis.
February 25, 2019
Two of the biggest pharmaceutical companies are joining forces in a blockbuster merger. Bristol-Myers Squibb is buying Celgene in a cash and stock deal valued at about $74 billion.
December 27, 2018
If you were following patent and innovation news in 2018, it was hard to avoid mentions of 3D printing.
November 29, 2018
IBM recently took a giant step forward to position itself as a leader in the new frontier of cloud computing.
November 20, 2018
It’s common for patent applications to suffer at least one rejection during prosecution. To overcome rejections, patent professionals will often request an interview with the assigned USPTO examiner. But are some examiners more receptive to interviews than others?